Solabegron

Overview

Solabegron (GW 427353) is a selective β 3 -adrenergic receptor agonist, stimulating cAMP accumulation in Chinese hamster ovary cells expressing the human β 3 -AR, with an EC 50 value of 22 nM. Solabegron (GW 427353) is being developed for the treatment of overactive bladder and irritable bowel syndrome.

Application

Products | Products > Disease Areas > Depression | Products > Disease Areas > SARS-CoV-2 Infection | Products > Disease Areas > Obesity | Products > Disease Areas > Infection | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Disease Areas > Coronavirus Infection | Products > Disease Areas > Lipid Metabolism | Products > Signaling Pathways > GPCR/G Protein | Products > Signaling Pathways > Neuronal Signaling | Products > Research Areas > Metabolic Disease | Products > Research Areas > Endocrinology | Products > Signaling Pathways > Adrenergic Receptor

Product Information

• Catalog No.: HY-19436
• CAS No.: 252920-94-8
• Molecular Formula: C23H23ClN2O3
• Molecular Weight: 410.89
• Purity: 99.89%
• Storage: 4°C, protect from light * In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)
• Solubility: ≥ 2.17 mg/mL (5.28 mM); Clear solution
• Availability: In-stock

Source

Original product source